Investor · New York, NY

Anat Nursella

Open Anat in the network graph →

Filings

3

SEC Form D

Connections

17

co-filers

Capital

$82.5M

across filings

Active

Apr 2024

to Apr 2025

Most-connected co-filers (17)

Henry C. Chen · Campbell, CA2 shared Roy Amariglio · New York, NY2 shared Tal Zaks, M.D., Ph.D · New York, NY2 shared Dylan Morris · Palo Alto, CA2 shared Aaron Nelson · Sheridan, WY2 shared Stephen Squinto · HANOVER, NH2 shared Erez Chimovits · Herzeliya, L31 shared Michal Silverberg · Menlo Park, CA1 shared Xiangmin Y. Cui · Camarillo, CA1 shared Yvonne Y. Chen · Camarillo, CA1 shared Sheila Y. Guirathi · Camarillo, CA1 shared Yvonne Yamanaka · Camarillo, CA1 shared Thomas Barnes, Ph.D · Watertown, MA1 shared Raju Prasad, Ph.D · Watertown, MA1 shared Cindy Xiong · Camarillo, CA1 shared Alex Harding · New York, NY1 shared Sumant Ramachandra · Camarillo, CA1 shared

Recent filings (3)

Averna Therapeutics Inc.Apr 2025 · 17 co-filers$85.0M Averna Therapeutics Inc.Apr 2025 · 17 co-filers$85.0M Exsilio Therapeutics Inc.Apr 2024 · 15 co-filers$85.0M Exsilio Therapeutics Inc.Apr 2024 · 15 co-filers$85.0M ImmPACT Bio USA Inc.Jan 2022 · 17 co-filers$110.9M ImmPACT Bio USA Inc.Jan 2022 · 17 co-filers$110.9M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Anat in the interactive graph →